MGI
RPRX icon

Miller Global Investments’s Royalty Pharma RPRX Stock Holding History

Miller Global Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598K Sell
10,673
-197
-2% -$10.3K 0.5% 63
2026
Q1 		$521K Sell
10,870
-25
-0.2% -$1.09K 0.48% 69
2025
Q4 		$421K Buy
+10,895
New +$415K 0.38% 87

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Miller Global Investments's RPRX Position: Q2 2026 in Review

Miller Global Investments reduced its Royalty Pharma (RPRX) stake by 1.8% in Q2 2026, selling an estimated $10.3K and leaving 10,673 shares worth $598K. The position accounts for 0.5% of the portfolio, ranked #63.

Miller Global Investments first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Miller Global Investments held 10,673 shares of Royalty Pharma worth $598K as of Q2 2026.
  • Miller Global Investments sold 197 Royalty Pharma shares in Q2 2026, an estimated $10.3K.
  • Royalty Pharma made up 0.5% of Miller Global Investments's portfolio in Q2 2026, its #63 holding.
  • Miller Global Investments first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.